Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Nov 11, 2020 6:49pm

299 Views

Post# 31882053

todays trades

House Positions for C:VXL from 20201111 to 20201111

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
9 BMO Nesbitt	50,000	4,740	0.095	0			50,000	-4,740
124 Questrade	23,500	2,115	0.09	0			23,500	-2,115
79 CIBC	25,500	2,295	0.09	5,125	436	0.085	20,375	-1,859
85 Scotia	11,500	1,072	0.093	2,273	194	0.085	9,227	-878
33 Canaccord	7,150	607	0.085	5,500	497	0.09	1,650	-110
89 Raymond James	110	9	0.082	1,000	90	0.09	-890	81
68 Leede	273	24	0.088	1,325	119	0.09	-1,052	95
1 Anonymous	227,125	20,186	0.089	236,150	21,407	0.091	-9,025	1,221
2 RBC	7,000	625	0.089	27,110	2,564	0.095	-20,110	1,939
80 National Bank	0			23,500	2,102	0.089	-23,500	2,102
7 TD Sec	50,825	4,336	0.085	101,000	8,600	0.085	-50,175	4,264
TOTAL	402,983	36,009	0.089	402,983	36,009	0.089	0	0